He P, Tang H, Zheng Y, Xu X, Peng X, Jiang T
Theranostics. 2025; 15(3):1017-1034.
PMID: 39776802
PMC: 11700863.
DOI: 10.7150/thno.102671.
Shao H, Lv K, Wang P, Jin J, Cai Y, Chen J
Front Microbiol. 2024; 15:1464088.
PMID: 39444679
PMC: 11496145.
DOI: 10.3389/fmicb.2024.1464088.
Shen Y, Zhou R, Bi L, Huang G, Yang M, Li Z
ACS Omega. 2024; 9(15):17423-17431.
PMID: 38645324
PMC: 11024937.
DOI: 10.1021/acsomega.4c00187.
Jane P, Xu X, Taelman V, Jane E, Gariani K, Dumont R
Nat Commun. 2023; 14(1):7329.
PMID: 37957176
PMC: 10643363.
DOI: 10.1038/s41467-023-43123-3.
Wu T, Liu C, Thamizhchelvan A, Fleischer C, Peng X, Liu G
Chem Biomed Imaging. 2023; 1(2):121-139.
PMID: 37235188
PMC: 10207347.
DOI: 10.1021/cbmi.3c00019.
Noninvasive imaging of the lung NETosis by anti-Ly6G iron oxide nanoparticles.
Zhong J, Zheng C, Gao H, Tong W, Hui H, Tian J
Heliyon. 2022; 8(8):e10043.
PMID: 35991979
PMC: 9382280.
DOI: 10.1016/j.heliyon.2022.e10043.
Rational design of fluorescent probe for Hg by changing the chemical bond type.
Cui T, Yu S, Chen Z, Liao R, Zhang X, Zhao Q
RSC Adv. 2022; 8(22):12276-12281.
PMID: 35539380
PMC: 9079269.
DOI: 10.1039/c8ra00295a.
Recent nanotheranostics applications for cancer therapy and diagnosis: A review.
Aminolroayaei F, Shahbazi-Gahrouei D, Shahbazi-Gahrouei S, Rasouli N
IET Nanobiotechnol. 2021; 15(3):247-256.
PMID: 34694670
PMC: 8675832.
DOI: 10.1049/nbt2.12021.
Novel EBV LMP1 C-terminal domain binding affibody molecules as potential agents for in vivo molecular imaging diagnosis of nasopharyngeal carcinoma.
Kamara S, Guo Y, Mao S, Ye X, Li Q, Zheng M
Appl Microbiol Biotechnol. 2021; 105(19):7283-7293.
PMID: 34505914
DOI: 10.1007/s00253-021-11559-6.
Nanobodies as , non-invasive, imaging agents.
Harmand T, Islam A, Pishesha N, Ploegh H
RSC Chem Biol. 2021; 2(3):685-701.
PMID: 34212147
PMC: 8190910.
DOI: 10.1039/d1cb00023c.
Nanoparticle-Based Activatable Probes for Bioimaging.
Ma T, Xia T
Adv Biol (Weinh). 2021; 5(1):e2000193.
PMID: 33724732
PMC: 7966733.
DOI: 10.1002/adbi.202000193.
Design of Cyclodextrin-Based Functional Systems for Biomedical Applications.
Xu W, Li X, Wang L, Li S, Chu S, Wang J
Front Chem. 2021; 9:635507.
PMID: 33681149
PMC: 7931691.
DOI: 10.3389/fchem.2021.635507.
Synthesis and Application of FeO@Au Composite Nanoparticles as Magnetic Resonance/Computed Tomography Dual-Modality Contrast Agent.
Keshtkar M, Shahbazi-Gahrouei D, Mahmoudabadi A
J Med Signals Sens. 2020; 10(3):201-207.
PMID: 33062612
PMC: 7528984.
DOI: 10.4103/jmss.JMSS_55_19.
Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer.
Baart V, Houvast R, de Geus-Oei L, Quax P, Kuppen P, Vahrmeijer A
EJNMMI Res. 2020; 10(1):87.
PMID: 32725278
PMC: 7387399.
DOI: 10.1186/s13550-020-00673-7.
Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells.
Zhu J, Kamara S, Cen D, Tang W, Gu M, Ci X
Cell Death Dis. 2020; 11(4):213.
PMID: 32238802
PMC: 7113277.
DOI: 10.1038/s41419-020-2410-7.
Synthesis Of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles With High Relaxivity For T/T Dual-Contrast Magnetic Resonance Imaging.
Xiao S, Yu X, Zhang L, Zhang Y, Fan W, Sun T
Int J Nanomedicine. 2019; 14:8499-8507.
PMID: 31695377
PMC: 6817351.
DOI: 10.2147/IJN.S219749.
Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy.
Cai X, Zhu Q, Zeng Y, Zeng Q, Chen X, Zhan Y
Int J Nanomedicine. 2019; 14:8321-8344.
PMID: 31695370
PMC: 6814316.
DOI: 10.2147/IJN.S218085.
Atheroprotective Mechanisms of Tilianin by Inhibiting Inflammation Through Down-Regulating NF-κB Pathway and Foam Cells Formation.
Shen W, Anwaier G, Cao Y, Lian G, Chen C, Liu S
Front Physiol. 2019; 10:825.
PMID: 31333487
PMC: 6614704.
DOI: 10.3389/fphys.2019.00825.
Gd @CNTs-PEG versus Gadovist®: In Vitro Assay.
Mehri-Kakavand G, Hasanzadeh H, Jahanbakhsh R, Abdollahi M, Nasr R, Bitarafan-Rajabi A
Oman Med J. 2019; 34(2):147-155.
PMID: 30918609
PMC: 6425045.
DOI: 10.5001/omj.2019.27.
A Novel Contrast Agent Based on Magnetic Nanoparticles for Cholesterol Detection as Alzheimer's Disease Biomarker.
Fernandez-Cabada T, Ramos-Gomez M
Nanoscale Res Lett. 2019; 14(1):36.
PMID: 30684043
PMC: 6349267.
DOI: 10.1186/s11671-019-2863-8.